Clinical Trials Insight: 700015615
Latest Information Update: 23 Jun 2009
Price :
$35 *
At a glance
- Drugs Influenza virus DNA vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 23 Jun 2009 Status changed from not stated to active, no longer recruiting.
- 21 Apr 2009 Results published in Vaccine.
- 04 Oct 2006 New trial record.